Delivery Order SPE2DR25D3014-SPE2DR26FP1SX
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $6,497.25 delivery order by the Defense Logistics Agency on January 21, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 22, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,091.56 by the Defense Logistics Agency (DLA) on January 27, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by January 28, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. Repatha is a prescription...
- The Defense Logistics Agency awarded a $6,211.30 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00 through December 2031, serves...
- The Defense Logistics Agency awarded a $9,747.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The order, with an ultimate completion date of January 23, 2026, was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under Cencora, Inc.'s...
- The Defense Logistics Agency awarded a $30,283.68 delivery order to AmerSourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 22, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of January 23, 2026. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a task...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $33,760.01 by the Defense Logistics Agency on January 27, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. The delivery order, which carries an ultimate completion date of January 28, 2026, represents a non-competitive award issued without set-aside designation. Performance will be executed from the awardee's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $46,000 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors, with performance completion targeted for January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,857.21 by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 12, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,258.92 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $44,909.34 by the Defense Logistics Agency on January 28, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be executed from the prime contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1SXDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $5,686.24 on January 27, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The Defense Logistics Agency (DLA) issued this firm fixed-price, non-set-aside contract, with performance to be completed by January 28, 2026, at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a task order execution under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $1 billion vehicle that serves as the primary mechanism for delivering pharmaceutical products and medical supplies to support military healthcare programs globally through December 2031. Repatha (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in patients with established coronary artery disease or other conditions. The SureClick auto-injector formulation provides convenient self-administration for patients requiring this specialty medication. As a major pharmaceutical distributor serving the federal government, Amerisourcebergen Drug Corp fulfills critical medical supply needs across the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems through its comprehensive supply chain capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 1/26/26 |